AI assistant
Cellectis — Regulatory Filings 2015
Mar 23, 2015
1190_rns_2015-03-23_72677b38-3145-4d52-b378-197e717fc6c9.zip
Regulatory Filings
Open in viewerOpens in your device viewer
CORRESP 1 filename1.htm Correspondence
Cellectis S.A.
8, rue de la Croix Jarry
75013 Paris, France
March 23, 2015
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Mr. Jeffrey P. Riedler
Mr. Johnny Gharib
Mr. Bryan Pitko
RE: Cellectis S.A.
Registration Statement on Form F-1 (File No. 333-202205)
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, Cellectis S.A. (the Registrant ) hereby requests that the Securities and Exchange Commission (the Commission ) take appropriate action to cause the above-referenced Registration Statement on Form F-1 to become effective on March 24, 2015 at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable. The Registrant hereby authorizes Boris Dolgonos, an attorney with our legal counsel, Jones Day, to orally modify or withdraw this request for acceleration. The Registrant also hereby requests a copy of the written order verifying the effective date.
In connection with this request, the Registrant acknowledges that:
should the Commission or the staff of the Commission (the Staff ), acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
the Registrant may not assert Staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Please contact Boris Dolgonos of Jones Day at (212) 326-3430 if you have any questions concerning the foregoing. Thank you for your attention to this matter.
| Very truly yours, | |
|---|---|
| CELLECTIS S.A. | |
| By: | /s/ André Choulika |
| André Choulika | |
| Chief Executive Officer |
cc: Boris Dolgonos, Jones Day